BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 30357319)

  • 21. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
    Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach.
    Shi L; Kojonazarov B; Elgheznawy A; Popp R; Dahal BK; Böhm M; Pullamsetti SS; Ghofrani HA; Gödecke A; Jungmann A; Katus HA; Müller OJ; Schermuly RT; Fisslthaler B; Seeger W; Fleming I
    Cardiovasc Res; 2016 Aug; 111(3):184-93. PubMed ID: 27013635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
    Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
    Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan.
    Clements RT; Vang A; Fernandez-Nicolas A; Kue NR; Mancini TJ; Morrison AR; Mallem K; McCullough DJ; Choudhary G
    Circ Heart Fail; 2019 Nov; 12(11):e005819. PubMed ID: 31707802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exercise facilitates early recognition of cardiac and vascular remodeling in chronic thromboembolic pulmonary hypertension in swine.
    Stam K; van Duin RWB; Uitterdijk A; Cai Z; Duncker DJ; Merkus D
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H627-H642. PubMed ID: 29167118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Right Ventricular Maladaptation to Pressure Overload in Fischer Rats Is Associated With Profound Deficiency in Adenylate Kinase 1 and Impaired Ventricular Energetics.
    Zelt JGE; Cadete V; Deng Y; Godoy R; Cuillerier A; Rowe K; Abdul-Ghani M; Megeney L; Burelle Y; Giulivi A; Stewart AFR; Provencher S; Breuils-Bonnet S; Bonnet S; deKemp R; Beanlands R; Mielniczuk LM; Stewart DJ
    Hypertension; 2022 Dec; 79(12):2774-2786. PubMed ID: 36278405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
    Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones.
    Frump AL; Goss KN; Vayl A; Albrecht M; Fisher A; Tursunova R; Fierst J; Whitson J; Cucci AR; Brown MB; Lahm T
    Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(9):L873-90. PubMed ID: 25713318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional and molecular determinants of right ventricular response to severe pulmonary hypertension in a large animal model.
    Brown RD; Hunter KS; Li M; Frid MG; Harral J; Krafsur GM; Holt TN; Williams J; Zhang H; Riddle SR; Edwards MG; Kumar S; Hu CJ; Graham BB; Walker LA; Garry FB; Buttrick PM; Lahm T; Kheyfets VO; Hansen KC; Stenmark KR
    Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H804-H820. PubMed ID: 36961489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
    Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK
    J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.
    Liu A; Schreier D; Tian L; Eickhoff JC; Wang Z; Hacker TA; Chesler NC
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H273-83. PubMed ID: 24906919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the microRNA signature driving adaptive right ventricular hypertrophy in an ovine model of congenital heart disease.
    Kameny RJ; He Y; Zhu T; Gong W; Raff GW; Chapin CJ; Datar SA; Boehme JT; Hata A; Fineman JR
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H847-H854. PubMed ID: 29906222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulators of right ventricular apoptosis and contractility in a rat model of pulmonary hypertension.
    Zungu-Edmondson M; Shults NV; Wong CM; Suzuki YJ
    Cardiovasc Res; 2016 May; 110(1):30-9. PubMed ID: 26790474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RV pressure overload: from hypertrophy to failure.
    van der Bruggen CEE; Tedford RJ; Handoko ML; van der Velden J; de Man FS
    Cardiovasc Res; 2017 Oct; 113(12):1423-1432. PubMed ID: 28957530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac remodelling in a swine model of chronic thromboembolic pulmonary hypertension: comparison of right vs. left ventricle.
    Stam K; Cai Z; van der Velde N; van Duin R; Lam E; van der Velden J; Hirsch A; Duncker DJ; Merkus D
    J Physiol; 2019 Sep; 597(17):4465-4480. PubMed ID: 31194256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct time courses and mechanics of right ventricular hypertrophy and diastolic stiffening in a male rat model of pulmonary arterial hypertension.
    Kwan ED; Vélez-Rendón D; Zhang X; Mu H; Patel M; Pursell E; Stowe J; Valdez-Jasso D
    Am J Physiol Heart Circ Physiol; 2021 Oct; 321(4):H702-H715. PubMed ID: 34448637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblasts and the extracellular matrix in right ventricular disease.
    Frangogiannis NG
    Cardiovasc Res; 2017 Oct; 113(12):1453-1464. PubMed ID: 28957531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertension.
    Antigny F; Mercier O; Humbert M; Sabourin J
    Arch Cardiovasc Dis; 2020 Jan; 113(1):70-84. PubMed ID: 31924541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-intensity interval training, but not continuous training, reverses right ventricular hypertrophy and dysfunction in a rat model of pulmonary hypertension.
    Brown MB; Neves E; Long G; Graber J; Gladish B; Wiseman A; Owens M; Fisher AJ; Presson RG; Petrache I; Kline J; Lahm T
    Am J Physiol Regul Integr Comp Physiol; 2017 Feb; 312(2):R197-R210. PubMed ID: 27784688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin Receptor-Neprilysin Inhibition Attenuates Right Ventricular Remodeling in Pulmonary Hypertension.
    Sharifi Kia D; Benza E; Bachman TN; Tushak C; Kim K; Simon MA
    J Am Heart Assoc; 2020 Jul; 9(13):e015708. PubMed ID: 32552157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.